Search Results

Press Releases

SEKISUI Completes £15.7 Million Expansion in cGMP Biopharma CDMO Capacity

November 15, 2024

·

2 min read

Genetown

SEKISUI Diagnostics Receives Emergency Use Authorization for the OSOM® Flu SARS-CoV-2 Combo Test

SEKISUI Diagnostics, a global medical diagnostics manufacturer, has received EUA clearance for the OSOM Flu SARS-CoV-2 Combo Test for use in professional and home testing settings.

March 5, 2024

·

2 min read

SEKISUI CHEMICAL CO., LTD. and RevolKa Signed a Contract Research Agreement

RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform signed a contract research agreement with SEKISUI CHEMICAL CO., LTD..

January 23, 2024

·

2 min read

Business

SEKISUI Diagnostics and Aptitude Partner to Provide Metrix™ COVID-19 Tests to the Point-of-Care and Home Test Markets

SEKISUI Diagnostics, a global medical diagnostics manufacturer, has formalized an exclusive distribution agreement with Aptitude Medical Systems (Aptitude™), an innovative developer of decentralized molecular diagnostics, to sell the Aptitude Metrix™ COVID-19 Test in the U.S.

January 3, 2024

·

3 min read

Genetown

SEKISUI Diagnostics announces the Launch of the OSOM® COVID-19 Antigen Home Test

SEKISUI Diagnostics announces the launch of the OSOM COVID-19 Antigen Home Test to diagnose COVID-19 at home.

July 31, 2023

·

2 min read

BioIVT Acquires XenoTech, a Leading Provider of Products and Services for Preclinical Testing of New Drug Candidates

BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today announced that it has acquired XenoTech, a provider of products for ADME-Tox in vitro models and contract research services, from Sekisui Chemical, based in Japan.

September 12, 2022

·

3 min read

Press Releases

Acella Pharmaceuticals, LLC, an Alora Pharmaceuticals, LLC Subsidiary, Partners with Paloma Health for Hypothyroidism Patients

October 23, 2024

·

2 min read

Deals

INTEGRATED ONCOLOGY NETWORK ANNOUNCES THE ACQUISITION OF UROLOGY PARTNERS, LLC

Integrated Oncology Network, LLC (“ION”), a portfolio company of Silver Oak Services Partners, LLC (“Silver Oak”), today announced the acquisition of Urology Partners, LLC.

May 2, 2024

·

3 min read

Press Releases

Rancho BioSciences, LLC Awarded Great Place to Work(R) Certification for the Third Consecutive Year

December 12, 2024

·

2 min read

Press Releases

ITF Therapeutics LLC Announces Appointment of Erica L. Monaco, CPA, as Chief Operating Officer

December 4, 2024

·

7 min read